If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

Share Price Information for Idox Group (IDOX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 65.00
Bid: 64.20
Ask: 65.80
Change: 0.60 (0.93%)
Spread: 1.60 (2.492%)
Open: 64.00
High: 65.00
Low: 64.00
Prev. Close: 64.40
IDOX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

16 Nov 2022 07:00

RNS Number : 5282G
IDOX PLC
16 November 2022
 

16 November 2022

Idox plc

('Idox', the 'Group' or the 'Company')

Year End Trading Update

A resilient performance

 

Idox plc (AIM: IDOX), a leading supplier of specialist information management software and solutions to the public and asset intensive sectors, today issues a trading update for its financial year ended 31 October 2022 ('FY22').

 

 

Group trading performance

 

We are pleased to report Idox has delivered a resilient performance for FY22 against a backdrop of economic uncertainty. We have continued to make progress towards a number of our medium-term strategic goals, putting the Group on a strong footing for the future.

 

Our focus on winning and retaining long-term recurring revenue contracts with high quality customers has resulted in record full year order intake in excess of c. £74m, up 19% on FY21, providing good visibility into FY23.

 

The Board expects to report (subject to audit) a c. 15% increase in full year adjusted EBITDA to c. £22.5m, in line with management's expectations. Revenue is expected to be up 6% to c. £66m, and recurring revenue is anticipated to be up c. 12% over the period to c. £40.5m. As a result, the Group expects to deliver an improved adjusted EBITDA margin of c. 34% (FY21: 31%).

 

The Group's net debt at year-end was £6.7m, a reduction since 31 October 2021 (£8.1m net debt). The Group continues to maintain significant balance sheet flexibility and strength, including a £35m revolving credit facility and a £10m accordion.

 

As reported in early October, Idox acquired Landhawk, a land mapping and GIS data business, for £1.5m, including an initial cash consideration of £1.1m. Landhawk further strengthens the Group's GIS capabilities following the acquisitions of Aligned Assets, thinkWhere and exeGesIS in FY21. We continue to pursue a number of acquisition opportunities but remain focussed on ensuring strategic alignment whilst maintaining a disciplined approach to valuations.

 

We have started FY23 with strong recurring revenue and good levels of contract renewals, a solid order book and a healthy pipeline. As a result, our expectations for FY23 remain unchanged, albeit we remain cognisant of the current economic environment.

 

 

David Meaden, Chief Executive Officer of Idox commented:

 

"We have laid the foundations for sustained success at Idox, and against a challenging macro-economic backdrop, we have delivered a robust set of results.

With recurring revenue and order intake up, we are well positioned to continue our success over the coming years, supported by a strong balance sheet.

 

Pleasingly, we have seen significant success in areas of strategic focus, notably with Idox Cloud where we have seen 15 new sales during the period, which bodes well for our future performance.

 The integration of recent acquisitions into the Group has progressed well and we have made several adjustments to our operating business, building capacity for future growth. I am pleased that our leadership development programme has ensured that all new senior appointees have been internal candidates.

 

We have a strong balance sheet position, leaving us well placed for an accretive buy and build programme. This, alongside our accelerating organic growth, will create significant value for shareholders and wider stakeholders going forward."

 

 

 

 

 

 

Notice of results

 

The Group expects to report its FY22 results in late January 2023. Management intends to host a results webinar on the day. Please contact MHP Communications to register your interest.

 

 

Definitions

 

Adjusted EBITDA is defined as earnings before amortisation, depreciation, restructuring, acquisition costs, impairment, financing costs and share option costs.

 

Net debt is defined as the aggregation of cash, bank borrowings and long-term bond.

 

 

For further information please contact:

 

Idox plc

Chris Stone, Non-Executive Chairman

David Meaden, Chief Executive Officer

Anoop Kang, Chief Financial Officer

 

+44 (0) 870 333 7101

investorrelations@idoxgroup.com

Peel Hunt LLP (NOMAD and Broker)

Paul Gillam

Michael Burke

James Smith

 

+44 (0) 20 7418 8900

MHP Communications

Reg Hoare

Ollie Hoare

Matthew Taylor

 

+ 44 (0) 20 3128 8276

idox@mhpc.com

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFELLFLFLLFBK
Date   Source Headline
14th Aug 20129:37 amRNSDirector/PDMR Shareholding
7th Aug 201210:03 amRNSDirector/PDMR Shareholding
26th Jun 201211:03 amRNSHolding(s) in Company
26th Jun 20127:00 amRNSInterim Management Statement
13th Jun 201210:21 amRNSHolding(s) in Company
29th May 20127:00 amRNSTrading Statement
25th May 20127:00 amRNSContract Win
23rd May 20127:00 amRNSContract win
3rd May 20127:00 amRNSAcquisition
18th Apr 20127:00 amRNSContract win
27th Mar 20122:48 pmRNSHolding(s) in Company
27th Mar 20127:00 amRNSAcquisition
8th Mar 20127:00 amRNSTransaction in Own Shares
1st Mar 20122:40 pmRNSAGM resolutions passed
1st Mar 20127:00 amRNSAGM Statement
23rd Feb 20127:00 amRNSDirector/PDMR Shareholding
14th Feb 20127:00 amRNSContract Win
13th Feb 201212:32 pmRNSHolding(s) in Company
8th Feb 20127:00 amRNSDirector/PDMR Shareholding
6th Feb 20127:00 amRNSNotice of AGM & Annual Report & Accounts
14th Dec 20114:21 pmRNSFinal Dividend
14th Dec 20117:00 amRNSFinal Results
6th Dec 20119:30 amRNSNotice of Results
17th Nov 20113:21 pmRNSHolding(s) in Company
15th Nov 20117:00 amRNSTrading Update
15th Nov 20117:00 amRNSAcquisition
7th Nov 20117:00 amRNSAcquisition
1st Nov 201111:04 amRNSHolding(s) in Company
5th Sep 20113:20 pmRNSTransaction in Own Shares
23rd Aug 20113:35 pmRNSTransaction in Own Shares
17th Aug 201110:50 amRNSHolding(s) in Company
9th Aug 201110:57 amRNSTransaction in Own Shares
9th Aug 201110:56 amRNSAdditional Listing
3rd Aug 20114:54 pmRNSPDMR
21st Jul 20117:00 amRNSGlobal Contract
28th Jun 201112:16 pmRNSHolding(s) in Company
27th Jun 201111:24 amRNSChange of Registered Office
14th Jun 20117:00 amRNSInterim results
14th Jun 20117:00 amRNSHolding(s) in Company
9th Jun 201111:19 amRNSHolding(s) in Company
6th Jun 20114:52 pmRNSHolding(s) in Company
2nd Jun 20111:51 pmRNSHolding(s) in Company
2nd Jun 20111:51 pmRNSHolding(s) in Company
31st May 201111:38 amRNSHolding(s) in Company
27th May 201110:43 amRNSNotice of Results
19th May 201112:28 pmRNSMerger Update
18th May 201111:10 amRNSHolding(s) in Company
18th May 20117:00 amRNSHalf year trading update
13th May 20112:47 pmRNSTransaction in Own Shares
5th May 20117:00 amRNSCompletion of acquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.